GEHC vs INDV: fair value comparison
GE HealthCare Technologies Inc. and Indivior Pharmaceuticals, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, INDV currently sits closer to the top of our ranking by discount to fair value.
| GEHC | INDV | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $65.74 | $32.45 |
| 12-month range | $59.48–$88.16 | $24.78–$41.83 |
| Rank by discount to fair value | #21 of 108 Healthcare | #17 of 108 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | Low |
| Margin trend | Expanding | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Mixed |
| 52-week position | The bottom quarter | The lower-middle quarter |
Full single-stock breakdowns: GEHC fair value analysis · INDV fair value analysis